MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

EEG dominant frequency as a potential biomarker of cognition in Lewy body diseases.

R. Heo, J. Wallner, N. Mukhopadhyay, D. Krusienski, M. Barrett (Richmond, USA)

Meeting: 2024 International Congress

Abstract Number: 122

Keywords: Cognitive dysfunction, Dementia with Lewy bodies (DLB), Electroencephalogram(EEG)

Category: Parkinson's Disease and Lewy Body Dementia

Objective: To determine whether cognitive performance correlates with posterior dominant frequency across Lewy body diseases.

Background: DLB and PDD are associated with prominent posterior slow-wave activity, i.e., reduced dominant frequency (DF), on EEG and this feature has been proposed as a supportive criterion for DLB[1]. Prior studies have restricted DF ranges between delta (3-3.5 Hz) and alpha (8-12 Hz) frequencies[2]. It is unknown if cognitive performance correlates with DF beyond this range.

Method: Two 5-minute segments of resting EEG data with eyes closed (EC) and eyes open (EO) were collected for 28 patients with diagnoses of DLB (n=13), PDD (n=6), and PD (n=9). Participants performed a cognitive battery. EEG data were processed using MATLAB software (r2023b). Continuous, artifact-free EEG segments of at least 50 seconds were manually identified and divided into 10-second non-overlapping epochs for each channel. Epochs were bandpassed from 0.25 to 30 Hz. The amplitude spectrum of each epoch was computed using Welch’s method with 128-sample windows and 64-sample overlap, zero-padded to 256 samples. The resulting spectra were transformed to log-log coordinates, and the linear trend was subtracted to remove the 1/f characteristic. The frequency bin with the largest magnitude was selected as the DF for each epoch. DF was averaged over all epochs in all posterior EEG channels. Correlation analyses were performed with averaged posterior DF and cognitive test scores.

Results: Mean age was 74 (SD=5.8) and there were 39% females. EO and EC DF each had a range of 9-33 Hz and mean of 20 (SD=7.7) and 19 (SD=8.1), respectively. Age was correlated with DF EO EEG DF (r=-0.36, p=0.049) but not EC EEG DF. EO and EC EEG DF values were negatively correlated with global cognition as measured by the Montreal Cognitive Assessment (r=-0.71, p<0.0001 and r=-0.70, p<0.0001, respectively). EO and EC EEG DF were also negatively correlated with tests of memory, executive function, and language; and EC EEG DF was negatively correlated with visuospatial function (all p<0.05).

Conclusion: DF, when assessed over an expanded frequency range, was highly negatively correlated with global cognition and moderately negatively correlated with tests of memory, executive function, visuospatial function, and language in PDD, DLB, and PD. This EEG feature should be further evaluated as a biomarker of cognitive status in Lewy body diseases.

References: 1. McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2017;89:88–100. https://doi.org/10.1212/WNL.0000000000004058.
2. Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M. EEG comparisons in early Alzheimer’s disease, dementia with Lewy bodies and Parkinson’s disease with dementia patients with a 2-year follow-up. Brain 2008;131:690–705. https://doi.org/10.1093/brain/awm322.

To cite this abstract in AMA style:

R. Heo, J. Wallner, N. Mukhopadhyay, D. Krusienski, M. Barrett. EEG dominant frequency as a potential biomarker of cognition in Lewy body diseases. [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/eeg-dominant-frequency-as-a-potential-biomarker-of-cognition-in-lewy-body-diseases/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/eeg-dominant-frequency-as-a-potential-biomarker-of-cognition-in-lewy-body-diseases/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley